Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
Abbott, abroad, Actelion, algorithm, Amgen, Apoteket, Apotheek, argument, auto, automobile, awaiting, banning, blended, burden, Cappucci, captionedTomeldon, Carolina, Centers®in, Chairman, claimant, clarified, commonwealth, contributor, cooperating, corroborated, Daschner, deferral, domestically, downgrade, drop, earliest, economy, ePrescribing, Euro, Europa, European, expert, export, FAS, footnote, FSPFIN, Gabriel, Gentiva, geopolitical, Germany, global, hardware, Harvard, hierarchy, hold, immune, ineffective, inEITF, instability, intention, IssueNo, keen, KPMG, landscape, learned, leaving, Maryland, Mayo, MedicarePart, metropolitan, Michigan, MIPPA, nonfinancial, observable, ofEITF, ofForm, oral, overpriced, Pitney, Plantm, Plavix, Plavix®benefit, postponed, prudent, ratified, reconsideration, restart, robust, Round, Score, secondary, semi, shown, simultaneously, slowdown, solutionstm, statistical, strong, susceptible, suspension, Sweden, Swedish, tamcomplaint, tammatter, Teva, thereunder, theRule, thirdqui, thisForm, tort, underEITF, underRule, University, unobservable, unpaid, variation, vast, Venlo, viewpoint, weak, Whitestown, withEITF, wraparound
Removed:
accelerate, anticipation, APB, approximate, array, captioned, CareFirst, closely, clotting, Connectivity, discrete, DUR, enrichment, extended, extra, extract, featuring, Genzyme, handheld, harmed, hospitalization, immateriality, immunoglobulin, inclusive, indenture, IVIG, marginal, MedImmune, misrepresentation, negligent, occasionally, prepaid, productivity, punitive, racketeering, recruiting, restraint, RxHub, sampling, Shelby, slightly, traffic, unearned, unfavorable, unjust, varying, yielded
Filing tables
Filing exhibits
- 10-K Annual report
- 10.3 EX-10.3: Second Amended and Restated Receivables Purchase Agreement
- 12.1 EX-12.1: Statement of Consolidated Ratios of Earnings to Fixed Charges
- 21.1 EX-21.1: Subsidiaries
- 23.1 EX-23.1: Consent of Pricewaterhousecoopers LLP
- 31.1 EX-31.1: Certification
- 31.2 EX-31.2: Certification
- 32.1 EX-32.1: Certification
- 32.2 EX-32.2: Certification
Related press release
MHS similar filings
Filing view
External links